Femasys (FEMY) Work In Process (2020 - 2026)
Femasys (FEMY) reported Work In Process of $1.6 million for Q1 2026, up 48.75% on a YoY basis from $1.1 million in Q1 2025, and up 25.09% quarter-over-quarter from $1.3 million in Q4 2025.
Femasys (FEMY) Work In Process (2020 - 2026) Analysis & Trends
Femasys has reported Work In Process for 7 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Work In Process rose 48.75% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 48.75% YoY), and the FY2025 full-year result was $1.3 million, up 28.89% from the prior year.
- Work In Process for Q1 2026 stood at $1.6 million, up from $1.3 million in the prior quarter.
- The five-year high for Work In Process was $1.6 million in Q1 2026, with the low at $51358.0 in Q3 2023.
- Historically, Work In Process has averaged $550761.8 across 5 years, with a median of $131657.0 in 2024.
- Annual changes were most pronounced in 2023 — Work In Process plunged 34.81% — and 2024, when it surged 891.5%.
- Femasys' Work In Process stood at $100453.0 in 2022, then increased by 28.41% to $128993.0 in 2023, then surged by 661.77% to $982630.0 in 2024, then advanced by 28.89% to $1.3 million in 2025, then increased by 25.09% to $1.6 million in 2026.
- The last three Work In Process figures came in at $1.6 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 982,630.00 |
| Sep 30, 2024 | 509,217.00 |
| Jun 30, 2024 | 229,045.00 |
| Mar 31, 2024 | 131,657.00 |
| Dec 31, 2023 | 128,993.00 |
| Sep 30, 2023 | 51,358.00 |
| Jun 30, 2023 | 71,081.00 |
| Mar 31, 2023 | 98,775.00 |
| Dec 31, 2022 | 100,453.00 |
| Sep 30, 2022 | 78,777.00 |
| Jun 30, 2022 | 98,403.00 |
| Mar 31, 2022 | 55,709.00 |
| Dec 31, 2021 | 12,795.00 |
| Sep 30, 2021 | 39,879.00 |
| Jun 30, 2021 | 26,348.00 |